Presented here is the Annual Scientific Report of the Georgia Cancer Center at Augusta University in Augusta, Georgia. The following pages describe the research achievements of Cancer Center members within the Cancer immunology, Inflammation, and Tolerance (CIT), Molecular Oncology and Biomarkers (MOB), and Tumor Signaling and Angiogenesis (TSA) basic science programs, as well as the Cancer Prevention, Control, and Population Health (CPCPH) program.
Under the leadership of Dr. Jorge Cortes, the Georgia Cancer Center has undergone unprecedented expansion in the number of research and clinical faculty over the past two years, with the recruitment of more than twenty new faculty. The plan is to further increase this number over the next three years to build the critical mass that is needed to achieve NCI designation through the National Cancer Institute’s Cancer Center Support Grant program by 2020. With this goal in mind, prioritized develop-ment of shared research resources provides access to state-of-the-art technologies to all Cancer Center members. Details of these shared facilities and the services they offer are included in this report.
Another essential facet of the Georgia Cancer Center’s Research program is its integration with the activities of the Georgia Cancer Center’s Educational program. Over the past year, new educational components have been developed to secure the best training for the next generation of physicians and scientists, to provide optimized idea exchange among established physicians and scientists, and to ensure that current clinical professionals integrate the best, most up-to-date practices in medicine. Co-operation between the research and educational programs ensures that Georgia Cancer Center patients benefit from the most recent research discoveries from around the world.
